NeoGenomics, Inc. (NEO)

Healthcare · Diagnostics Research · NASDAQ

NeoGenomics, Inc. (NEO) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $2.13B, a trailing price-to-earnings ratio of 110.5 and a free-cash-flow yield of -1.0%. Over the most recent reported fiscal year, revenue grew 10.1%.

Market cap	$2.13B
Trailing P/E	110.5
FCF yield	-1.0%
Revenue growth (YoY)	+10.1%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Diagnostics Research

Explore live NEO data on Nama Insights →

Recent Congressional trades

NeoGenomics, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Dwight Evans	House	Sell	$1,001 - $15,000	Apr 20, 2022
Deborah K. Ross	House	Buy	$15,001 - $50,000	Dec 30, 2021
Bob Gibbs	House	Sell	$1,001 - $15,000	Nov 9, 2021
Dwight Evans	House	Buy	$1,001 - $15,000	Apr 2, 2020